+ PUBLICATIONS
1. Transposition of the great arteries in a cat. Straw RC, Aronson EF, McCaw DL: J Am Vet Med Assoc 1985;187:634-636. |
2. Idiopathic hematuria of unilateral renal origin in a dog. Hitt ME, Straw RC, Lattimer JC, Shaw DP et al: J Am Vet Med Assoc 1985;187:1371-1373. |
3. Use of radiation for the treatment of intranasal tumors in cats: six cases (1980-1985). Straw RC, Withrow SJ, Gillette EL, McChesney AE: J Am Vet Med Assoc 189:927-929, 1986. |
4. Contamination with skin bacteria during orthopedic and neurosurgical procedures in dogs. |
5. Jamshidi needle biopsy for diagnosis of bone lesions in small animals. Powers BE, LaRue SM, Withrow SJ, Straw RC et al: J Am Vet Med Assoc 193:205-210, 1988. |
5. Radiographic Bone Surveys. Straw RC, Cook NL, LaRue SM, Withrow SJ, Wrigley RH. J Am Vet Med Assoc. 1989 Dec 1;195(11):1458.
|
7. Prognosis for the treatment of tumors. Curtis CR, Straw RC. J Am Vet Med Assoc. 1989 Feb 1;194(3):324-5. |
8. Multilobular osteochondrosarcoma of the canine skull: sixteen cases (1978-1988). Straw RC, LeCouteur RA, Powers BE, Withrow SJ: J Am Vet Med Assoc 195:1764-1769, 1989. |
9. Resection of the nasal planum in nine cats and five dogs. Withrow SJ, Straw RC: J Am Anim Hosp Assoc 26:219-222, 1990. |
10. Limb sparing treatment for osteosarcoma in dogs. |
11. Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: A dose response assay. Thrall DE, Withrow SJ, Powers BE, Straw RC et al: Int J Rad Onc Biol Phys 18:1354-1357, 1990. |
12. Amputation and cisplatin for treatment of canine osteosarcoma. Straw RC, Withrow SJ, Richter SL et al: J Vet Int Med, 5:205-210, 1991. |
13. Primary osteosarcoma of the ulna in 12 dogs. Straw RC, Withrow SJ, Powers BE: Primary osteosarcoma of the ulna in 12 dogs. J Am Anim Hosp Assoc 27:323-326, 1991 |
14. Comparative aspects of osteosarcoma: dog vs. man. Withrow SJ, Powers BE, Straw RC, Wilkins RM: Clin Orthop Rel Res, 270:159-167, 1991. |
15. Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma.
|
16. Toxicosis associated with the administration of mitoxantrone to dogs with malignant tumors. |
17. Efficacy of mitoxantrone against various neoplasms in dogs. |
18. Prevalence of nephrotoxicity associated with a short-term saline diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989). Ogilvie GK, Straw RC, Powers BE, Cooper MF, Withrow SJ. J Am Vet Med Assoc, 199:613-616, 1991. |
19. The effect of intramedullary polymethylmethacrylate on healing of intercalary cortical allografts in a canine model. Straw RC, Powers BE, Withrow SJ, Cooper MF, Turner AS. J Orthop Res, 10:434-439, 1992. |
20. Retrospective study of 26 primary tumors of the osseous thoracic wall in dogs. The Veterinary Cooperative Group: Montgomery RD, Henderson RA, Powers RD, Withrow SJ, Straw RC et al. J Am Anim Hosp Assoc, 29: 68-72, 1993. |
21. Partial or total hemipelvectomy in the management of sarcomas in seven dogs and two cats. Straw RC, Withrow SJ, Powers BE. Vet Surg, 21:183-188, 1992. |
22. Partial maxillary resection as a treatment of oral cancer in 61 dogs. Schwarz PD, Withrow SJ, Curtis CR, Straw RC, Powers BE. J Am Anim Hosp Assoc, 27:617-624, 1991. |
23. Mandibular resection as a treatment of oral cancer in 81 dogs. Schwarz PD, Withrow SJ, Curtis CR, Straw RC, Powers BE. J Am Anim Hosp Assoc, 27:601-610, 1991. |
24. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma. Withrow SJ, Powers BE, Straw RC, et al. Chir Organi Mov 1990;75(1 Suppl):29-31. |
25. Toxicosis and efficacy associated with the administration of mitoxantrone to cats with malignant tumors. |
26. Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas. |
27. Squamous cell carcinoma of the tongue in 10 dogs. Carpenter LG, Withrow SJ, Powers BE, Ogilvie GK, Schwarz PD, Straw RC, LaRue SM, Berg RJ. J Am Anim Hosp Assoc, 29:17-24, 1993. |
28. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). |
29. Prevalence of nephrotoxicosis associated with four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms. |
30. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: (1987-1991). |
31. The effects of cis-diamminedichloroplatinum II released from D,L-polylactic acid implanted adjacent to cortical allografts in dogs. |
32. Resection of pulmonary metastases in canine osteosarcoma: 36 cases (1983-1992). |
33. Evaluation of the osteoinductive capacity of canine demineralized bone matrix in heterotopic muscle sites of athymic rats. Forell EB, Straw RC, Powers BE, Johnson J, Cooper MF, Lowry J, Withrow SJ. Vet Comp Ortho Traum, 1993;6:21-28. |
34. Bone morphogenetic proteins and bone derived growth factors. Forell EB, Straw RC. Vet Comp Ortho Traum, 1993;6:166-171. |
35. Infiltrative lipoma in dogs: 16 cases (1981-1992). Bergman PJ, Withrow SJ, Straw RC, Powers BE. J Am Vet Med Assoc 1994;205:322-324. |
36. Canine thymoma: 23 cases (1988-1991). |
37. Intra-arterial cisplatin with or without radiation in limb sparing for canine osteosarcoma. Withrow SJ, Thrall DE, Straw RC, Powers BE, Wrigley RH, LaRue SM, Page RL, Deyoung DJ, Richter SL, Jameson VJ, George SL, Dodge R, Gillette EL, Douple EB. Cancer 1993;71:2484-2490. |
38. Recent advances in the treatment of canine appendicular osteosarcoma. O'Brien MG, Straw RC, Withrow SJ. Compend Prac Vet 1993;7:939-946. |
39. Partial and total scapulectomy in the dog. Kirpensteijn J, Straw RC, Pardo AD, Adams WH, Withrow SJ, Calhoon CS. J Am Anim Hosp Assoc 1994;30:313-319. |
40. Histologically low grade, yet biologically high grade, fibrosarcomas of the mandible and maxilla in dogs: 25 cases (1982-1991). Ciekot PA, Powers, BE, Withrow SJ, Straw RC, Ogilvie GK, LaRue SMJ Am Vet Med Assoc 1994;4:610-615. |
41. The impact of heterogeneity in the predictive value of kinetic parameters in canine osteosarcoma. |
42. Combined resection of the nasal planum and premaxilla in three dogs. Kirpensteijn J, Withrow SJ, Straw RC. Vet Surg 23:341-346, 1994. |
43. Primary osteosarcoma distal to the antebracheocarpal and tarsocrural joints in dogs (1980-1992). |
44. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991-1993). |
45. Primary rib tumors in 54 dogs. |
46. Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989) |
47. Canine mandibular osteosarcoma: 51 cases, (1980-1992). |
48. Total and partial orbitectomy for the treatment of periorbital tumors in 24 dogs and 6 cats. |
49. Feline Cutaneous Squamous Cell Carcinoma of the Nasal Planum and the Pinnae: 61 Cases. Lana SE, Ogilvie GK, Withrow SJ, Straw, RC, Rogers KS, J Amer Anim Hosp Assoc 1997; 33: 329-332. |
50. Digital pad transposition for replacement of the metacarpal or metatarsal pad in dogs. Olsen D, Straw RC, Withrow SJ, Basher AWP. J Am Anim Hosp Assoc 1997;33:337-341. |
51. Adjuvant Chemotherapy Using Cisplatin by Subcutaneous Administration. Dernell WS, Withrow SJ, Straw RC, Lafferty MH. In Vivo 1997; 11:345-350. |
52. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). |
53. Multilobular Osteochondrosarcoma in 39 Dogs: 1979-1993. |
54. Outcome Following Treatment of Vertebral Tumors in 20 Dogs (1986-1995). Kuntz CA, Asselin TL, Dernell WS, Powers BE, Straw RC, Withrow SJ. Vet Surg 1998;27:417-422.
|
55. Intracavity Treatment of Soft Tissue Sarcomas in Dogs Using Cisplatin in a Biodegradable Polymer. Dernell WS, Withrow SJ, Straw RC, et al. Anticancer Research 1997;17:4499-4506. |
56. Limb Salvage Surgery for Osteosarcoma of the Proximal Humerus: Outcome in 17 Dogs. Kuntz CA, Asselin TL, Dernell WS, Powers BE, Straw RC, Withrow SJ. Vet Surg 1998;27:417-422. |
57. Comparison of Cemented and Non-cemented Allografts in Dogs with Osteosarcoma. Kirpensteijn J, Steinheimer D, Park RD, Powers BE, Straw RC, Endenburg N, Withrow SJ. Vet Comp Orthop Traumatol 1998; 11: 178-84. |
58. Apparent interaction of dimethyl sulfoxide with cisplatin released from polymer delivery devices injected subcutaneously in dogs. |
59. Effects of a controlled-release cisplatin delivery system used after resection of mammary carcinoma in mice. |
60. Combined Dorsolateral and Intraoral Approach for the Resection of Tumors of the Maxilla in the Dog. |
61. Transposition of the dew claw for reconstruction of carpal pad defect in a cat with soft tissue sarcoma. |
62. Clinical evaluation of mitoxantrone and Piroxicam in a canine model of human invasive bladder carcinoma |
63. Intra-abdominal lipoma in a dog. Gibbons SE, Straw RC. J Aust Vet Pract 2003, 33:86, 86-88.
|
64. Matrix Metalloproteinase –2 and –9 Involvement in Canine Tumors. Loukopoulos P, Mungall BA, Straw RC, Thornton JR, Robinson WF. Vet Path 2003 Jul;40(4):382-94.
|
65. Repair of Three Pathological Fractures in a dog with multiple myeloma. Banks TA, Langova V, Straw RC. Aust Vet Pract 2003, 33:98, 98-102. |
66. Radial and Distal Humeral Osteosarcoma in 12 Dogs. |
67. Grafts for Joint and Limb Preservation in 17 Dogs with High-Grade Malignant Tumours of the Diaphysis. |
68. Treatment of Eight Dogs with Nasal Tumours with Alternating Doses of Doxorubicin and Carboplatin in Conjunction with Oral Piroxicam. Langova V, Mutsaers AJ, Phillips B, Straw R Aust Vet J. 82;11 Nov 2004:676-680. |
69. Multilobular Osteosarcoma of the Hard Palate in a Dog. |
70. Biodegradable Cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Withrow SJ, Liptak JM, Straw RC, Dernell WS, Jameson VJ, Powers BE, Johnson JL, Brekke JH, Douple EB. |
71. Insulinoma and Concurrent Diabetes Mellitus in a Boxer-cross Dog. Stenner V, Langova V, Straw R. Aust Vet Practit 2003;33:150-154. |
72. Surgical Resection of Retrobulbar Infiltrative Lipomas in Two Dogs. Langova V, Straw R, Price T. Aust Vet Practit 2004;34:6-10. |
73. Chondroblastoma in the Carpus of a Cat. Langova V, Straw R, Wilkie, Powers B. Aust Vet Practit 2004;34:76-78. |
74. Treatment of Canine Osteosarcoma with Surgery, Carboplatin, Doxorubicin and Piroxicam. Langova V, Straw R, Mutsaers A, Thamm D. Aust Vet Practit 2004;34:98-102. |
75. Soft Tissue Sarcomas in Dogs: a Study Assessing Surgical Margin with Tumour Grade and Outcome. Banks T, Straw R, Thomson M, Powers B. Aust Vet Practit. 2004 |
76. Improved Survival Associated With Postoperative Wound Infection in Dogs Treated With Limb-Salvage Surgery for Osteosarcoma. Lascelles BDX, Dernell WS, Correa MT, Lafferty M, Devitt CM, Kuntz CA, Straw RC, Withrow SJ.Ann Surg Oncol 12(12): 1-11, 2005.
|
77. Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer cell.
|
78. Biological Behavior and Clinical Outcome of 25 Dogs with Canine Appendicular Chondrosarcoma Treated by Amputation: A Veterinary Society of Surgical Oncology Retrospective Study |